Literature DB >> 7675768

Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus.

N S Aguilera1, S B Kapadia, M A Nalesnik, S H Swerdlow.   

Abstract

The diagnosis of extramedullary plasmacytomas (EMP) is usually easy to conform with immunohistochemical stains for kappa and lambda. In some cases, however, immunostains are problematic. In addition, prognostic features are not well described nor is it known whether EMP are associated with the Epstein-Barr virus. Therefore, 23 EMP of the head and neck (from 20 patients) were studied to (1) compare a non-isotopic paraffin section in situ hybridization technique for kappa and lambda mRNA with standard immunohistochemical techniques for assessing light chain expression, (2) compare the histologic grade to the proliferative fraction using an antibody for the proliferating cell nuclear antigen, and (3) determine the frequency of Epstein-Barr virus (EBV) association using probes for the EBV DNA (EBV NOT 1) and RNA (EBER-1). Light chain class restriction was demonstrated in 22/23 biopsies by in situ hybridization and in 21/23 biopsies by standard immunohistochemical techniques. Five of the six biopsies of well-differentiated EMP had proliferating cell nuclear antigen scores of 0 to 10% positive cells and one had 11 to 25% positive cells compared with greater than 75% in the one poorly differentiated EMP. Of 15 moderately differentiated EMP, 10 had proliferating cell nuclear antigen scores of 11 to 75%, and 5 had scores of greater than 75%. EBV DNA was detected in 1/23 biopsies and EBV RNA in 4/23 biopsies (3 patients). Thus, non-isotopic in situ hybridization is a useful technique to document clonality of plasma cells in routinely fixed, paraffin-embedded sections. Unlike routine immunohistochemistry, in situ hybridization avoids the problem of detecting stromal or nonspecific uptake of immunoglobulin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675768

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  11 in total

1.  Epstein-Barr virus in malignancies in renal transplant recipients in Japan.

Authors:  Y Hoshida; Y Tomita; M Ohsawa; X Ning; K Aozasa
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Comparison of in situ hybridisation and polymerase chain reaction in the diagnosis of B cell lymphoma.

Authors:  A M McNicol; M A Farquharson; F D Lee; A K Foulis
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

3.  EBV-positive plasmacytoma of the submandibular gland--report of a rare case with molecular genetic characterization.

Authors:  Benedict Yan; Soo Yong Tan; Ee Xuan Yau; Siok Bian Ng; Fredrik Petersson
Journal:  Head Neck Pathol       Date:  2011-03-26

Review 4.  Expect the Unexpected: Report of a Case of Pediatric Pharyngeal Extraosseous Plasmacytoma with Tumefactive Amyloidosis ("Amyloidoma") and a Review of the Literature.

Authors:  Char Loo Tan; Sze Hwa Tan; Siok Bian Ng; Fredrik Petersson
Journal:  Head Neck Pathol       Date:  2015-02-12

Review 5.  Epstein-Barr virus-positive multiple myeloma developing after immunosuppressant therapy for rheumatoid arthritis: a case report and review of literature.

Authors:  Yasunobu Sekiguchi; Asami Shimada; Kunimoto Ichikawa; Mutsumi Wakabayashi; Keiji Sugimoto; Keigo Ikeda; Iwao Sekikawa; Shigeki Tomita; Hiroshi Izumi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ohta; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

6.  An immunocompetent patient with a recurrence-free Epstein-Barr virus positive plasmacytoma possesses robust Epstein-Barr virus specific T-cell responses.

Authors:  Bithi Chatterjee; Laura Sahli; Obinna Chijioke; Philip Went; Christian Münz; Andreas Trojan
Journal:  Haematologica       Date:  2017-07-13       Impact factor: 9.941

Review 7.  [B-cell neoplasms with plasmacellular and plasmablastic differentiation].

Authors:  F Fend; L Quintanilla-Martínez
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

8.  Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.

Authors:  Ghaleb Elyamany; Ali Matar Alzahrani; Muna Aljuboury; Najlah Mogadem; Nagham Rehan; Omar Alsuhaibani; Abdulaziz Alabdulaaly; Eman Al-Mussaed; Imad Elhag; Abdullah AlFiaar
Journal:  Diagn Pathol       Date:  2015-06-25       Impact factor: 2.644

9.  Epstein-Barr virus-positive ileal extraosseous plasmacytoma containing plasmablastic lymphoma components with CD20-positive lymph node involvement.

Authors:  Makoto Saito; Masanobu Morioka; Ko Izumiyama; Akio Mori; Tatsuro Irie; Masanori Tanaka; Yoshihiro Matsuno
Journal:  Int J Gen Med       Date:  2012-08-23

10.  Plasma cell neoplasms in US solid organ transplant recipients.

Authors:  Eric A Engels; Christina A Clarke; Ruth M Pfeiffer; Charles F Lynch; Dennis D Weisenburger; Todd M Gibson; Ola Landgren; Lindsay M Morton
Journal:  Am J Transplant       Date:  2013-05-01       Impact factor: 9.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.